Home › Trial NCT04547335
The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole
- Trial IDNCT04547335
- StatusUnknown
- PhaseN/A
- Study typeObservational
- SponsorDokuz Eylul University
- Enrollment34
- Start date2019-11-01
- ConditionsAdverse Drug Reactions
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.